Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Pint of Science is the world’s largest public science festival bringing researchers to local pubs, cafes and spaces to share their scientific discoveries with the public.

© Emma Phillipson

This year, Pint of Science 2022 is taking place from 9 – 11 May 2022, with three nights in Oxford devoted to the popular ‘Our Body’ theme. The first, held at St Aldates Tavern, focused on heart disease and regeneration. Dr Joaquim Vieira, BHF Basic Science Research Fellow and Principal Investigator at the Institute of Developmental and Regenerative Medicine (IDRM), talked about ‘Uncovering the silent genes behind heart regeneration’, which generated a lively discussion and was followed by a science quiz.

There is presently no effective treatment available to mend the heart after a heart attack. Recent work from Dr Vieira has shown that the heart attempts to replenish its damaged tissue by reverting to similar processes that were used in the embryo to build the heart before birth. It is important to understand the molecular mechanisms behind heart development in order to identify new targets for adult heart repair and regeneration.

Dr Vieira investigates how epicardial cells become activated and invade the heart’s myocardial layer in a process called the epithelial-to-mesenchymal transition (EMT), which is necessary for the formation of coronary blood vessels and cardiac muscle. Once the heart is fully formed, these cells form a protective outer later, and no longer help to produce new blood vessels and muscle cells. This means the heart has very limited regenerative potential and cannot compensate for the major loss of cells caused by a heart attack. The Vieira Group aims to understand how the EMT process works during development, with particular attention to the WT1 gene, which controls epicardial cell activation, before switching off in the adult heart. The ultimate goal is to reactivate the EMT process in the adult heart and harness the regenerative potential of the epicardium.

Following his talk on Monday night, Dr Vieira said: “I truly enjoyed the opportunity to share with the wider public our research to better understand gene regulation in the context of heart development and response to injury. As a researcher and junior group leader, I believe it is important to step out of our comfort zone and participate in initiatives such as Pint of Science to promote public engagement with science and raise awareness to the work sponsored by BHF being developed here in DPAG.”

Similar stories

AI analysis of routine heart scans can predict risk of developing heart problems ten years in advance, new research finds

A research team led by scientists at the Radcliffe Department of Medicine, University of Oxford has developed an Artificial Intelligence (AI) technology which can accurately predict the risk of a heart attack, heart failure or cardiac death from routine cardiac CT scans, up to ten years in advance.

University of Oxford research receives £5 million funding boost from British Heart Foundation

The BHF has renewed their support for the Oxford Centre of Research Excellence, which underpins the wide network of cardiovascular researchers across the University.

Pawel Swietach elected to membership of Academia Europaea

We are delighted to report that DPAG’s Professor Pawel Swietach was elected to membership of Academia Europaea. Pawel has joined the Physiology and Neuroscience section of the Academy.

Wellcome Career Development Awards success for Betty Raman

Congratulations to Associate Professor Betty Raman former BHF Oxford CRE Transition Fellow, on being warded a Wellcome Career Development Award.

British Heart Foundation partners with the Oxford-Cambridge Boat Race

The British Heart Foundation (BHF) is the official charity partner for The Gemini Boat Race. Oxford cardiovascular research DPhil students Catherine King (IDRM) and Claire Aitken (RDM) are funded by the BHF and proud to be part of this year’s race.

Heather Group publishes new paper in Diabetes journal

Professor Lisa Heather and colleagues have just published a new paper, ‘Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of its Pathology’ in the journal Diabetes.

Similar stories

AI analysis of routine heart scans can predict risk of developing heart problems ten years in advance, new research finds

A research team led by scientists at the Radcliffe Department of Medicine, University of Oxford has developed an Artificial Intelligence (AI) technology which can accurately predict the risk of a heart attack, heart failure or cardiac death from routine cardiac CT scans, up to ten years in advance.

University of Oxford research receives £5 million funding boost from British Heart Foundation

The BHF has renewed their support for the Oxford Centre of Research Excellence, which underpins the wide network of cardiovascular researchers across the University.

Pawel Swietach elected to membership of Academia Europaea

We are delighted to report that DPAG’s Professor Pawel Swietach was elected to membership of Academia Europaea. Pawel has joined the Physiology and Neuroscience section of the Academy.

Wellcome Career Development Awards success for Betty Raman

Congratulations to Associate Professor Betty Raman former BHF Oxford CRE Transition Fellow, on being warded a Wellcome Career Development Award.

British Heart Foundation partners with the Oxford-Cambridge Boat Race

The British Heart Foundation (BHF) is the official charity partner for The Gemini Boat Race. Oxford cardiovascular research DPhil students Catherine King (IDRM) and Claire Aitken (RDM) are funded by the BHF and proud to be part of this year’s race.

Heather Group publishes new paper in Diabetes journal

Professor Lisa Heather and colleagues have just published a new paper, ‘Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of its Pathology’ in the journal Diabetes.